Myriad Genetics' Q4, FY '09 Revenues Rise on MDx Sales Increase | GenomeWeb

NEW YORK (GenomeWeb News) – Myriad Genetics reported after the close of the market Monday that its fourth-quarter and fiscal-year 2009 revenues increased 33 percent and 47 percent, respectively, on increased sales of its molecular diagnostic products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.